tailieunhanh - Clonal tracing reveals diverse patterns of response to immune checkpoint blockade

Immune checkpoint blockade (ICB) therapy has improved patient survival in a variety of cancers, but only a minority of cancer patients respond. Multiple studies have sought to identify general biomarkers of ICB response, but elucidating the molecular and cellular drivers of resistance for individual tumors remains challenging. |

TỪ KHÓA LIÊN QUAN